The Federal Agency for Medicines and Health Products (FAMHP) is holding a symposium on vaccines on Friday 6 December 2019. The symposium will highlight certain current challenges in the development of new vaccines and the improvement of existing vaccines. Spekers will also talk about the role of various Belgian public institutions in bringing vaccines to market and monitoring them.
This event is open to a wide audience: scientists from academia and industry, health professionals, vaccine experts from regional and federal public institutions, and anyone interested in the field of vaccination.
When Friday 6 December 2019 from 09:00 to 16:45
Where Pacheco Center - Boulevard Pachéco, 13 - 1000 BRUSSELS
Practical information Presentations will be given in English. Participation is free of charge but requires registration using the online form. At the end of the symposium, the FAMHP will issue a certificate to participants.
Read the programme for the Vaccine Symposium.
Morning: Discovering and developing new vaccines
Welcome, registration and coffee
Introduction – Xavier De Cuyper, Xavier De Cuyper, Chief Executive Officer of the Federal Agency for Medicines and Health Products (FAMHP)
Pertussis vaccines: from whole cell to acellular vaccines and why better vaccines are still needed - Camille Locht (Institut national de la santé et de la recherche médicale – INSERM)
Ebola and vaccine emergency access in Europe and western countries - Nele Berthels (FAMHP)
Shingrix as a case study to illustrate marketing authorisation procedure – Didier Hue (FAMHP)
Quality requirement for vaccines and future perspective - Koen Brusselmans (Sciensano)
FAMHP vaccine news - Stéphanie Mali (FAMHP)
Adverse events following immunisation: from their notification to their interpretation - Françoise Wuillaume (FAMHP)
Afternoon: Vaccine Implementation
Tuberculosis vaccines: rising opportunities - Johan Vekemans (World Health Organisation - WHO)
Implementation of vaccination program in Belgium - Paloma Carrillo (Office de la Naissance et de l'Enfance - ONE) - Geert Top (Agentschap Zorg en Gezondheild - Vlaanderen)
Societal impact of vaccination: beyond individual protection - Nicolas Dauby (CHU Saint-Pierre/UMC Sint-Pieter)
Polio eradication: what is needed to eradicate polio? Where are we now in Belgium? - Charles Denonne (Federal Public Service Health, Food Chain Safety and Environment)
Epidemiologic surveillance to inform and assess Belgium’s vaccine policies: strengths and challenges - Chloé Wyndham-Thomas (Sciensano)